A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

A nationwide cohort study suggests clarithromycin-based therapy for Helicobacter pylori eradication is safe in patients with stable coronary heart disease and subsequent peptic ulcer disease

Abstract Background Clarithromycin-based therapy is important for Helicobacter pylori eradication treatment. However, clarithromycin may increase cardiovascular risk. Hence, we investigated the association between clarithromycin use and outcomes in adults with stable coronary heart disease (CHD) and...

Full description

Bibliographic Details
Main Authors: Yen-Chun Chen, Yi-Da Li, Ben-Hui Yu, Yi-Chun Chen
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Gastroenterology
Subjects:
Clarithromycin
Overall mortality
Cardiovascular mortality
Cardiovascular morbidity
Peptic ulcer disease
Helicobacter pylori
Online Access:https://doi.org/10.1186/s12876-022-02498-1

Internet

https://doi.org/10.1186/s12876-022-02498-1

Similar Items